Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.

EJVES Vascular Forum, published by Elsevier, is a premier open access journal focusing on the interdisciplinary field of vascular surgery and cardiovascular medicine. Since its inception in 2001, the journal has provided a vital platform for the dissemination of high-quality research and innovative clinical practices, addressing critical issues in vascular health. With an ISSN of 2666-688X, it has gained recognition within its community, attaining a Q3 quartile ranking in both cardiology and surgery categories as of 2023, and showcasing its relevance and impact within the medical research landscape. Situated in the United Kingdom and accessible globally, the EJVES Vascular Forum invites contributions that foster collaboration and enhance knowledge in vascular surgery, making it an essential resource for researchers, professionals, and students alike. The journal's ranking within Scopus highlights its position among peers, adding further credence to its objectives of advancing science and improving patient care in the cardiovascular realm. By publishing rigorously peer-reviewed articles, the journal aims to be the go-to source of information and innovation for those dedicated to the progress of vascular health.

The International Forum of Allergy & Rhinology, published by Wiley, is a leading journal dedicated to advancing the field of allergy, rhinology, and related health issues. With an ISSN of 2042-6976 and an E-ISSN of 2042-6984, this esteemed journal showcases high-quality research and innovative findings by publishing original articles, reviews, and clinical case studies. As of 2023, it holds impressive rankings within the Scopus metrics, placing it in the top 2% for Medicine in Otorhinolaryngology and in the top 16% for Immunology and Allergy, highlighting its influence and credibility in these specialized fields. Operating without an open access model, the journal aims to offer comprehensive insights into the diagnosis and treatment of allergic conditions and their impact on rhinology, fostering a deeper understanding among researchers and practitioners. Located in Hoboken, NJ, the journal has been at the forefront of scientific exploration since its inception in 2011, continuing to play a pivotal role in informing the academic community and influencing clinical practice up to 2024 and beyond.

Metabolic Syndrome and Related Disorders is an esteemed journal published by MARY ANN LIEBERT, INC, focusing on the multifaceted aspects of metabolic syndrome, including its interaction with chronic diseases such as diabetes, cardiovascular conditions, and obesity. Since its inception in 2003, this journal has established itself as a vital resource for researchers, healthcare professionals, and students dedicated to advancing knowledge in the fields of endocrinology, internal medicine, and metabolic disorders. With an impact factor reflective of its academic significance, Metabolic Syndrome and Related Disorders is recognized within the Q2 and Q3 quartiles in its respective categories, solidifying its reputation among scientific and clinical communities. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and reviews that foster innovative solutions and improve patient outcomes. The journal's gradual convergence towards 2024 presents an exciting opportunity for continued exploration and dialogue about metabolic-related health challenges.

Journal of Dermatology & Dermatologic Surgery (JDDS) is a premier open access journal published by Wolters Kluwer Medknow Publications since 2018. This journal serves as a vital platform for the dissemination of cutting-edge research and advancements in the field of dermatology and dermatologic surgery. With its ISSN 2352-2410 and E-ISSN 2352-2429, JDDS strives to present high-quality articles that encompass clinical studies, innovative surgical techniques, and comprehensive reviews, thereby catering to the interests of researchers, medical professionals, and students alike. The journal has gained recognition within the academic community, evidenced by its Scopus ranks, placing it 237th out of 551 in the Medicine - Surgery category and 70th out of 142 in Medicine - Dermatology. The open access model not only enhances visibility but also encourages global collaboration and knowledge sharing in the rapidly evolving field of dermatology. Targeting the needs of diverse audiences, JDDS continues to foster an environment for scholarly communication and contributes significantly to the advancement of dermatologic sciences.

Therapeutic Advances in Allergy and Rhinology, published by SAGE Publications Inc, is an esteemed journal that focuses on advancing the fields of allergy and rhinology through innovative and impactful research. As an Open Access journal, it provides a platform for researchers, clinicians, and students to share significant findings and therapeutic developments aimed at improving patient outcomes related to allergic conditions and nasal disorders. The journal aims to publish high-quality peer-reviewed articles, reviews, and case studies that contribute to a deeper understanding of the pathophysiology and management of allergies and rhinological conditions. By fostering collaborative dialogue across various disciplines, Therapeutic Advances in Allergy and Rhinology plays a crucial role in enhancing clinical practice and guiding future research in this vital area of health. With an ISSN of 2753-4030, the journal continues to establish itself as a key resource for anyone involved in allergy and rhinology research and practice.

CLINICAL OTOLARYNGOLOGY is a prestigious peer-reviewed journal published by Wiley that focuses on advancing research in the field of otorhinolaryngology, including topics such as laryngeal surgery, sinus diseases, and head and neck oncology. With an ISSN of 1749-4478 and an E-ISSN of 1749-4486, this journal has established itself as a vital resource for healthcare professionals, researchers, and students interested in ear, nose, and throat (ENT) medicine. The journal is recognized for its rigorous standards, exemplified by its Q2 ranking in both the Medicine (Miscellaneous) and Otorhinolaryngology categories, as per the 2023 Scopus ranking, placing it within the 71st percentile among global journals in its field. Operating from its UK base in Hoboken, NJ, CLINICAL OTOLARYNGOLOGY also contributes to the scientific community's understanding of this specialized area of medicine, with a publication timeline spanning from 2005 to 2024. While it does not offer an open-access model, the journal's quality and impact make it a crucial platform for disseminating high-caliber research that informs clinical practices and fosters innovation in otolaryngology.

ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery is a prestigious peer-reviewed journal, published by KARGER, dedicated to advancing the field of otorhinolaryngology. With a rich history dating back to 1938, this journal addresses crucial developments in the diagnosis and treatment of disorders affecting the ear, nose, throat, and related structures of the head and neck. As per the 2023 Scopus rankings, it holds a commendable position of Q3 in the otorhinolaryngology category, showcasing its relevance and contribution to medical research. Currently indexed with an ISSN of 0301-1569 and an E-ISSN of 1423-0275, the journal fosters an academic environment for researchers, practitioners, and students to share their findings, case studies, and reviews. Although it operates on a traditional subscription model, its significant impact on the field makes it an essential resource for enhancing knowledge and practice in head and neck surgery. By encouraging rigorous research, ORL remains at the forefront of otorhinolaryngology, addressing the ever-evolving challenges and innovations in this dynamic medical specialty.

Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.

Laryngoscope Investigative Otolaryngology is a prominent open access journal published by Wiley, dedicated to advancing research and knowledge within the field of otolaryngology and surgical practices. Since its inception in 2016, this journal has undergone a transformative phase and has quickly established itself in the academic community, achieving Q2 quartile rankings in both Otorhinolaryngology and Surgery for the year 2023. With an ISSN of 2378-8038, it serves as a vital repository of innovative research, insights, and reviews, catering primarily to researchers, medical professionals, and students. The journal emphasizes accessibility, allowing wide dissemination of pivotal findings essential for fostering collaboration and enhancing clinical practices. Through its rigorous peer-review process and commitment to quality, Laryngoscope Investigative Otolaryngology seeks to contribute significantly to the ongoing dialogue and improvements within the health care landscape.